Sartorius (SRT3) Given a €76.00 Price Target at Commerzbank

Sartorius (FRA:SRT3) has been given a €76.00 ($90.48) target price by Commerzbank in a research report issued to clients and investors on Wednesday. The firm presently has a “neutral” rating on the stock. Commerzbank’s price objective indicates a potential downside of 12.64% from the company’s previous close.

SRT3 has been the topic of a number of other reports. Berenberg Bank set a €85.00 ($101.19) target price on shares of Sartorius and gave the stock a “buy” rating in a research report on Tuesday, October 17th. Kepler Capital Markets set a €78.00 ($92.86) target price on shares of Sartorius and gave the stock a “neutral” rating in a research report on Thursday, January 4th. Nord/LB set a €70.00 ($83.33) target price on shares of Sartorius and gave the stock a “sell” rating in a research report on Wednesday, October 25th. Warburg Research set a €100.00 ($119.05) target price on shares of Sartorius and gave the stock a “buy” rating in a research report on Wednesday, October 25th. Finally, Hauck & Aufhaeuser set a €60.00 ($71.43) target price on shares of Sartorius and gave the stock a “sell” rating in a research report on Thursday, October 26th. Three investment analysts have rated the stock with a sell rating, five have issued a hold rating and two have given a buy rating to the stock. The stock presently has a consensus rating of “Hold” and an average target price of €78.40 ($93.33).

Sartorius (FRA SRT3) opened at €87.00 ($103.57) on Wednesday. Sartorius has a 12-month low of €63.72 ($75.86) and a 12-month high of €94.00 ($111.90). The company has a market cap of $6,520.00 and a price-to-earnings ratio of 70.73.

COPYRIGHT VIOLATION NOTICE: “Sartorius (SRT3) Given a €76.00 Price Target at Commerzbank” was first published by BBNS and is the property of of BBNS. If you are accessing this story on another site, it was stolen and reposted in violation of US & international trademark and copyright law. The original version of this story can be read at https://baseballnewssource.com/markets/sartorius-srt3-given-a-76-00-price-target-at-commerzbank/1822484.html.

Sartorius Company Profile

Sartorius Aktiengesellschaft provides laboratory and process technologies and equipment worldwide. The company operates through two divisions, Bioprocess Solutions, and Lab Products & Services. The Bioprocess Solutions division offers products, technologies, and services ranging from fermentation, cell cultivation, filtration, and purification to media storage and transportation for the biopharmaceutical industry.

Analyst Recommendations for Sartorius (FRA:SRT3)

Receive News & Ratings for Sartorius Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sartorius and related companies with our FREE daily email newsletter.

 


Latest News

Houston Astros Add Starter to Rotation
Houston Astros Add Starter to Rotation
Sources: Mets Bringing Back Jay Bruce with Three-Year Deal
Sources: Mets Bringing Back Jay Bruce with Three-Year Deal
Justin Morneau Former Star With Twins and AL MVP Retires
Justin Morneau Former Star With Twins and AL MVP Retires
MLB Rumor: Pirates Discussing Andrew McCutchen with Mets
MLB Rumor: Pirates Discussing Andrew McCutchen with Mets
Trade Rumor: Manny Machado Could Land With Yankees
Trade Rumor: Manny Machado Could Land With Yankees
Los Angeles Dodgers Acquire Scott Alexander as Part of Three Team Deal
Los Angeles Dodgers Acquire Scott Alexander as Part of Three Team Deal


Leave a Reply

 
© 2006-2018 BBNS.